Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,126 | -149,338 | -110,144 | -74,741 | -37,169 |
| Depreciation Amortization | -3,964 | -3,349 | -1,327 | -298 | -42 |
| Accounts receivable | 2,082 | N/A | -4,539 | N/A | -6,260 |
| Accounts payable and accrued liabilities | 3,707 | -1,319 | 1,445 | 769 | 2,562 |
| Other Working Capital | -486 | 1,656 | -12,313 | -14,947 | -8,273 |
| Other Operating Activity | 559 | 18,675 | 16,097 | 6,980 | 7,251 |
| Operating Cash Flow | $-39,228 | $-133,675 | $-110,781 | $-82,237 | $-41,931 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,915 | -186,413 | -48,784 | -41,766 | 8,182 |
| PPE Investments | N/A | 225 | 225 | N/A | N/A |
| Investing Cash Flow | $19,915 | $-186,188 | $-48,559 | $-41,766 | $8,182 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -20,996 | -20,998 | N/A | N/A |
| Common Stock Issued | 2,474 | 193,250 | 29,750 | 22,277 | 557 |
| Financing Cash Flow | $2,474 | $172,254 | $8,752 | $22,277 | $557 |
| Beginning Cash Position | 74,471 | 222,080 | 222,080 | 222,080 | 222,080 |
| End Cash Position | 57,632 | 74,471 | 71,492 | 120,354 | 188,888 |
| Net Cash Flow | $-16,839 | $-147,609 | $-150,588 | $-101,726 | $-33,192 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,228 | -133,675 | -110,781 | -82,237 | -41,931 |
| Free Cash Flow | -39,228 | -133,675 | -110,781 | -82,237 | -41,931 |